Kyowa Kirin Co Ltd
XMUN:KY4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Kyowa Kirin Co Ltd (KY4) under the Base Case is 15.65 EUR per share.
Compared with the current market price of 14.3 EUR, the stock appears
Undervalued by 9% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Kyowa Kirin Does
Kyowa Kirin is a Japanese pharmaceutical company that develops, makes, and sells prescription medicines. Its main business is creating drugs for serious conditions such as blood disorders, kidney-related diseases, and rare diseases, then bringing those medicines to hospitals and specialists who treat those patients. It also works on research and development, which is the starting point for its future drug pipeline.
- Headquarters
- Japan JP
- Employees
- 5 161
- IPO date
- Aug 22, 1949
Balance Sheet
Continue KY4 Research
Decided on Kyowa Kirin? Get an email when KY4 reaches the price you’d buy at. Free with an account.
Other Kyowa Kirin listings
What is the Intrinsic Value of one KY4 stock?
The intrinsic value for
Kyowa Kirin Co Ltd (KY4) under the Base Case is 15.65 EUR.
Is KY4 stock undervalued or overvalued?
Compared with the current market price of 14.3 EUR, the stock appears Undervalued by 9% .